Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LPAAU
4901
Launch One Acquisition Corp Unit
LPAAU
| $3.65K | ﹤0.01% |
344
| – | – |
2024 Q3
5 quarters
|
|
4902
Tilly's
TLYS
$140M
| $3.53K | ﹤0.01% |
1,772
| – | – |
2016 Q3
37 quarters
|
|
4903
Arcos Dorados Holdings
ARCO
$1.5B
| $3.52K | ﹤0.01% |
+479
| New | +$3.45K |
2025 Q4
0 quarters
|
|
|
ORIS
4904
DELISTED
Oriental Rise Holdings
ORIS
| $3.48K | ﹤0.01% |
584
-666
| -53% | -$6.9K |
2025 Q3
1 quarter
|
|
|
MGIC
4905
DELISTED
Magic Software Enterprises
MGIC
| $3.42K | ﹤0.01% |
133
-798
| -86% | -$18.4K |
2023 Q2
10 quarters
|
|
4906
iShares MSCI Germany ETF
EWG
$1.5B
| $3.4K | ﹤0.01% |
80
-186
| -70% | -$7.7K |
2023 Q4
8 quarters
|
|
4907
Polestar Automotive Holding ADS Class C-1
PSNYW
$688M
| $3.31K | ﹤0.01% |
520
-1
| -0.2% | -$7 |
2022 Q2
14 quarters
|
|
|
ZSEP
4908
Innovator Equity Defined Protection ETF - 1 Yr September
ZSEP
$229M
| $3.27K | ﹤0.01% |
+122
| New | +$3.25K |
2025 Q4
0 quarters
|
|
4909
AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF
SIXP
$52.9M
| $3.25K | ﹤0.01% |
103
-1,115
| -92% | -$34.7K |
2025 Q1
3 quarters
|
|
4910
AllianzIM U.S. Equity Buffer10 Feb ETF
FEBT
$162M
| $3.24K | ﹤0.01% |
85
-3,913
| -98% | -$147K |
2025 Q2
2 quarters
|
|
|
NCSM
4911
DELISTED
NCS Multistage Holdings
NCSM
| $3.24K | ﹤0.01% |
82
| – | – |
2025 Q2
2 quarters
|
|
|
EGHAU
4912
EGH Acquisition Corp Unit
EGHAU
| $3.14K | ﹤0.01% |
+306
| New | +$3.19K |
2025 Q4
0 quarters
|
|
|
CIGL
4913
Concorde International Group
CIGL
$92.5M
| $3.1K | ﹤0.01% |
1,926
| – | – |
2025 Q3
1 quarter
|
|
4914
InMode
INMD
$811M
| $3.04K | ﹤0.01% |
207
-18
| -8% | -$265 |
2022 Q1
15 quarters
|
|
4915
Natural Resource Partners
NRP
$1.45B
| $3.03K | ﹤0.01% |
29
+21
| +263% | +$2.19K |
2025 Q2
2 quarters
|
|
|
SBR
4916
Sabine Royalty Trust
SBR
$1.03B
| $3.02K | ﹤0.01% |
44
+3
| +7% | +$218 |
2025 Q3
1 quarter
|
|
4917
VirTra
VTSI
$31.6M
| $2.96K | ﹤0.01% |
706
| – | – |
2024 Q2
6 quarters
|
|
4918
iShares MSCI Europe Financials ETF
EUFN
$3.87B
| $2.93K | ﹤0.01% |
79
-2,933
| -97% | -$102K |
2025 Q2
2 quarters
|
|
4919
Valaris Ltd Warrants
VAL.WS
$586M
| $2.82K | ﹤0.01% |
1,605
| – | – |
2022 Q1
15 quarters
|
|
4920
Brilliant Earth
BRLT
$23.5M
| $2.65K | ﹤0.01% |
1,515
-11
| -0.7% | -$23 |
2021 Q4
16 quarters
|
|
4921
CVR Partners
UAN
$1.32B
| $2.56K | ﹤0.01% |
25
-33
| -57% | -$3.14K |
2025 Q3
1 quarter
|
|
|
BGSI
4922
Boyd Group Services
BGSI
$2.18B
| $2.55K | ﹤0.01% |
+16
| New | +$2.56K |
2025 Q4
0 quarters
|
|
4923
Passage Bio
PASG
$13.3M
| $2.5K | ﹤0.01% |
212
| – | – |
2022 Q1
15 quarters
|
|
|
HLSQ
4924
Tessera Defense and Homeland Security Inc.
HLSQ
$972K
| $2.46K | ﹤0.01% |
132
| – | – |
2024 Q2
6 quarters
|
|
|
DDFS
4925
Innovator Equity Dual Directional 15 Buffer ETF - September
DDFS
$86.2M
| $2.39K | ﹤0.01% |
+113
| New | +$2.37K |
2025 Q4
0 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.